ALLMedicine™ Intraocular Pressure Center
Research & Reviews 6,090 results
https://doi.org/10.1007/s10792-022-02313-6 10.1001/archopht.1977.04450030060003 10.1136/bjo.73.9.693 10.2147/OPTH.S85851 10.1097/00055735-200204000-00009 10.1111/j.1755-3768.1993.tb08591.x 10.1155/2020/6023586 10.1007/978-3-319-95046-4_51 10.1080/13816810.2018.1490961 10.1186/s12886-019-1277-9 10.3109/13816810.2011.567884 10.1007/s10792-013-9771-1 10.1167/iovs.09-3479 10.1167/iovs.11-8115 10.1136/bjophthalmol-2019-315086 10.1016/j.preteyeres.2009.04.002 10.1111/j.1755-3768.2011.2422.x 10.1007/s00417-020-04834-1
International Ophthalmology; Parameswarappa DC, Doctor MB et. al.
May 19th, 2022 - To assess the clinical characteristics of comorbid retinal dystrophies and primary angle closure disease. Retrospective study from January 1992 to June 2020. This descriptive study included 92 eyes of 46 patients with comorbid retinal dystrophies ...
https://doi.org/10.1097/IJG.0000000000002052
Journal of Glaucoma; Ibarz Barberá M, Galdón FM et. al.
May 19th, 2022 - The PSM® is a safe and effective glaucoma micro-filtering implant that significantly reduces the intraocular pressure, either alone or in combination with phacoemulsification, during the first year after surgery. To assess the safety and efficacy ...
https://doi.org/10.1167/iovs.63.5.18
Investigative Ophthalmology & Visual Science; Su CC, Gao CM et. al.
May 18th, 2022 - To investigate the pathogenesis of cytomegalovirus (CMV)-associated anterior segment infection in immunocompetent hosts and evaluate the effects of ganciclovir and glucocorticoid treatment in management of the disease. We used an inoculation model...
https://doi.org/10.1038/s41467-022-29860-x 10.1126/sciadv.1601314 10.1126/sciadv.aba3252 10.1038/nnano.2016.38 10.1038/nnano.2014.38 10.1038/s41551-020-00604-w 10.1038/s41586-018-0823-6 10.1038/nrdp.2016.67 10.1016/S0140-6736(17)31469-1 10.1038/85446 10.1097/00061198-200306000-00009 10.1089/10807680260362687 10.1039/C8LC00758F 10.1038/clpt.2008.297 10.2165/11533180-000000000-00000 10.1002/adhm.201400504 10.3390/s18082651 10.1021/acs.nanolett.9b03605 10.1039/C9LC01268K 10.1126/sciadv.aap9841 10.1021/acsnano.7b07082 10.1167/tvst.9.4.1 10.1109/JMEMS.2019.2927232 10.1038/s41551-021-00719-8 10.1021/nn5002968 10.1002/adhm.201600775 10.1016/j.addr.2017.04.001 10.1002/adfm.201901474 10.1038/s41928-019-0304-4 10.1016/j.matt.2020.12.002 10.1126/sciadv.aay0764 10.1002/aisy.201900190 10.1038/s41551-018-0336-5 10.1016/j.sna.2013.08.029 10.1002/adma.201702800 10.1016/j.ejpb.2019.04.016 10.1126/science.1143254 10.1002/smll.201702479 10.1109/PROC.1984.12959 10.1038/s41551-021-00685-1 10.1208/s12248-010-9183-3 10.1002/adfm.201907378 10.1073/pnas.1701740114 10.1006/exer.2001.1098 10.1016/j.jconrel.2016.02.012
Nature Communications; Yang C, Wu Q et. al.
May 18th, 2022 - Engineering wearable devices that can wirelessly track intraocular pressure and offer feedback-medicine administrations are highly desirable for glaucoma treatments, yet remain challenging due to issues of limited sizes, wireless operations, and w...
https://doi.org/10.1186/s12886-022-02448-1 10.1167/iovs.11-7480 10.1097/IJG.0b013e318241ba1d 10.1001/archopht.1982.01030030927004 10.1016/S0002-9394(00)00621-8 10.1016/j.ophtha.2018.01.015 10.1016/S0140-6736(18)32607-2 10.1167/tvst.8.2.5 10.1038/eye.2010.201 10.1371/journal.pone.0178079 10.1167/iovs.16-19755 10.1097/IJG.0000000000001654 10.1016/j.ophtha.2016.08.020 10.1111/aos.13190 10.1097/IJG.0000000000001572 10.1136/bjo.87.4.399 10.1167/iovs.61.5.40 10.1167/iovs.11-9359 10.1016/bs.pbr.2015.05.001 10.1016/j.ophtha.2021.01.021 10.3109/02713683.2012.655396 10.1097/IJG.0000000000000788 10.1136/bmjophth-2016-000058 10.1007/s10384-011-0009-3 10.1016/S0161-6420(13)31434-1 10.1016/S0140-6736(16)30956-4 10.1371/journal.pone.0162283 10.1016/j.survophthal.2020.04.003 10.1016/j.ophtha.2014.03.039 10.1016/j.ophtha.2006.06.053 10.1097/IJG.0b013e3181f7b26f 10.1016/j.ajo.2017.08.016
BMC Ophthalmology; Yu B, Wang K et. al.
May 17th, 2022 - Primary angle closure glaucoma (PACG) is the most common type of glaucoma in China. Laser peripheral iridotomy (LPI) is the primary choice to treat PAC: We aim to evaluate the changes of biometric parameters of anterior segment and to find possibl...
Guidelines 2 results
https://doi.org/10.3928/23258160-20160224-01
Ophthalmic Surgery, Lasers & Imaging Retina; Puliafito CA, Cousins SW et. al.
Apr 21st, 2016 - The diabetic macular edema (DME) treatment paradigm has evolved as the understanding of the disease pathology has grown. Since 2012, four pharmacotherapies have been approved by the U.S. Food and Drug Administration for the treatment of DME. First...
https://allmedx.com/USPSTFPDF/glaucomasumm.pdf
Jul 2nd, 2013 - SCREENING FOR GLAUCOMA CLINICAL SUMMARY OF U.S. PREVENTIVE SERVICES TASK FORCE RECOMMENDATION Population Adults without vision symptoms who are seen in primary care Recommendation No recommendation. Grade: I statement Ris...
Drugs 278 results see all →
Clinicaltrials.gov 396 results
https://clinicaltrials.gov/ct2/show/NCT01033422
May 12th, 2022 - This is a Phase 2, randomized, double-masked, placebo-controlled, parallel-group study in adult males and females, aged 18 years and over, with a diagnosis of glaucoma or ocular hypertension. This trial will be performed in 2 segments. In Segment ...
https://clinicaltrials.gov/ct2/show/NCT05372562
May 12th, 2022 - Patients who were diagnosed as postoperative CME after uneventful intraocular surgery and administrated with intravitreal OZURDEX injection were reviewed. All patients underwent ophthalmic examinations at the initial visit and were followed up at ...
https://clinicaltrials.gov/ct2/show/NCT04747808
May 10th, 2022 - This is an open-label, Phase 2a clinical study of LL-BMT1 in patients with primary open-angle glaucoma and ocular hypertension. Study subjects will be treated for 7 days with a single dose of LL-BMT1.
https://clinicaltrials.gov/ct2/show/NCT04024293
May 10th, 2022 - While elevated intraocular pressure (IOP) is no longer part of the definition of glaucoma it remains the sole proven modifiable risk factor for the onset and progression of glaucoma. IOP is known to vary with the time of day as well as with daily ...
https://clinicaltrials.gov/ct2/show/NCT05366647
May 9th, 2022 - Study aims to compare the effectiveness and safety profile of Gonioscopy-assisted Transluminal Trabeculotomy and canaloplasty, in order to find out if one operation is superior to the other. Both procedures are performed in patients with medically...
News 395 results
https://www.medscape.com/viewarticle/974081
May 19th, 2022 - Iqbal "Ike" K. Ahmed, MD, is a world-renowned ophthalmologist whose clinical work and research focus on glaucoma, complex cataracts, and intraocular lens complications. In 2020, The Ophthalmologist Power List named Dr Ahmed the second most influen...
https://www.onclive.com/view/treatment-of-keratopathy-associated-with-belantamab-mafodotin
Mar 20th, 2022 - Sagar Lonial, MD, FACP: Dr Klugo, I want to come back to some of the belantamab [mafodotin]-associated keratopathy. You mentioned the KVA [Keratopathy and Visual Acuity] scale as a way to measure severity. Are there any data on how to treat belama...
https://www.medscape.com/viewarticle/962994
Nov 15th, 2021 - NEW ORLEANS, Louisiana — An experimental new drug for glaucoma and ocular hypertension is as effective as latanoprost but causes different adverse events, the results of a phase 3 clinical trial suggest. Approved in Japan in 2018 and under review ...
https://www.medscape.com/viewarticle/962425
Nov 9th, 2021 - Study Summary The HORIZON trial, which compared cataract surgery alone with cataract surgery in conjunction with implantation of the Hydrus Microstent (Ivantis, Inc; Irvine, California), concluded at 3 years that the combination surgery was more e...
https://www.medscape.com/viewarticle/956893
Aug 19th, 2021 - Nonsteroidal anti-inflammatory drugs (NSAIDs) given as eye drops appear to work as well alone as they do in combination with steroids to prevent swelling of the macula after cataract surgery, researchers say. The anti-inflammatory eye drops worked...
